OPTimising a Screening Program to Detect Pacemaker-associated Heart Failure Using Artificial Intelligence
OPT-AI
1 other identifier
observational
150
1 country
1
Brief Summary
Pacemakers are an effective treatment for slow heart rates which improve symptoms and save lives. However, for some people pacemakers can cause heart failure (HF) because of the unnatural way in which they stimulate heart beats. In several studies conducted in West Yorkshire we showed that \~1/3 of patients with pacemakers have undiagnosed HF. We also showed that where HF is discovered, treating it with safe and inexpensive medications reduces the chances of being admitted to hospital or dying. However, detecting HF requires an echocardiogram (a heart ultrasound scan) which takes \~45 minutes, requires a skilled technician, and costs £120; or, to put it another way \~£540,000 to assess the \~4,500 patients cared for at our hospital. A new approach is needed. We think that using new technologies can improve our ability to screen for HF in people with pacemakers. We will test two approaches. First, we will assess whether a hand-held echocardiogram can measure heart function using artificial intelligence (AI) as accurately as a standard echocardiogram done by a skilled technician. Second, we will assess whether a finger-prick blood test can detect the presence of abnormal function as accurately as a standard echocardiogram.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2025
CompletedStudy Start
First participant enrolled
October 7, 2025
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
January 28, 2026
January 1, 2026
11 months
September 29, 2025
January 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The accuracy of artificial intelligence derived left ventricular ejection fraction (LVEF) compared to expert sonographer measured LVEF
Determined by the individual equivalence coefficient of artificial intelligence (AI) derived left ventricular ejection fraction (LVEF) versus to sonographer measured LVEF. The accuracy of AI LVEF will be compared to sonographer measured LVEF for non-inferiority. The pre-determined non-inferiority margin is 0.25 for the upper bound of the 95% confidence interval for this comparison.
Day 1
Secondary Outcomes (3)
Accuracy of artificial intelligence derived left ventricular ejection fraction of <50%
Day 1
Prediction of left ventricular ejection fraction <50%
Day 1
The utility of artificial intelligence echocardiography
Day 1
Eligibility Criteria
Patients with previously implanted pacemakers for bradycardia.
You may qualify if:
- Adult patients aged ≥18 years
- Patients with existing pacemakers who have a right ventricular pacing burden ≥20%.
- Ability to provide informed consent
You may not qualify if:
- Patients who are unwilling or unable to provide informed consent.
- Patients known to have heart failure
- Patients with any previous measurement of left ventricular ejection fraction \<50%.
- Patients with conduction system pacemakers.
- Patients with cardiac resynchronisation therapy pacemakers/defibrillators.
- Patients with implantable cardioverter defibrillators.
- Patients with leadless pacemakers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Leeds Hospitals Charitycollaborator
- University of Leedslead
Study Sites (1)
Cardiovascular Research Facility, Leeds General Infirmary
Leeds, LS1 3EX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Lecturer in Cardiology
Study Record Dates
First Submitted
September 29, 2025
First Posted
January 28, 2026
Study Start
October 7, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share